REMAST cell therapy

N/A

Report date: 2025/06/11 20:01:15

Base Information

Drug NameREMAST cell therapy
Drug Alias Nameautologous blood-derived tumour and hypoxia educated macrophages (Hemera Srl)
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Macrophages therapy
Mechanisms of ActionNeuroprotectants
TargetsNot applicable
Therapy Area/IndicationsSpinal Cord Injuries
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryEuropeItaly
CombinationsNo
Global Highest StatusClinical
Highest Status in ChinaN/A
Originator CompaniesHemera Srl
China Registration ClassN/A

Develop Information

Active CompaniesHemera Srl
Inactive CompaniesN/A
Active IndicationsSpinal Cord Injuries
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A